EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Allogeneic Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis. Two Sides of the Locket: Trigger or Cure?

Ahmet Alparslan Ceran, Tuğçe Yıldız, İrem Eser Sarı, Ahmet Şeyhanlı, Zeynep Arzu Yeğin, Zübeyde Nur Özkurt, Münci Yağcı

Mediterranean Journal of Hematology and Infectious Diseases · 01.09.2026 · 18 (1) · e2026073

DOI: 10.4084/mjhid.2026.073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediterranean Journal of Hematology and Infectious Diseases, online erschienen am 01.09.2026. Verfasst von Ahmet Alparslan Ceran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Gazi University Faculty of Medicine, Ankara, Turkey. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic hematopoietic stem cell transplantation (alloHSCT) represents a paradoxical role in hemophagocytic lymphohistiocytosis (HLH): curative in primary disease yet potentially triggering secondary HLH in the posttransplant setting. We report two adult cases illustrating this duality. The first case developed life-threatening secondary HLH on day +40 following haploidentical alloHSCT, presenting with extreme hyperferritinemia and procalcitonin elevation mimicking septic shock, successfully treated with dexamethasone, ruxolitinib, and plasma exchange. The second case underwent alloHSCT as definitive therapy for familial HLH harboring a UNC13D variant, achieving complete remission despite posttransplant EBV reactivation and lymphoproliferative disorder. These cases highlight the diagnostic challenges and therapeutic complexity of HLH within the transplant continuum.

Schlagwörter

Stichwörter der Autor:innen

Allogeneic Bone Marrow TransplantationEndothelial SyndromesFamilial Hemophagocytic LymphohistiocytosisHemophagocytic LymphohistiocytosisInflammationRuxolitinib

Autor:innen und Institutionen

  • Department of Hematology, Gazi University Faculty of Medicine, Ankara, Turkey.

Zitieren

APA

Ceran, A. A., Yıldız, T., Sarı, İ. E., Şeyhanlı, A., Yeğin, Z. A., Özkurt, Z. N., & Yağcı, M. (2026). Allogeneic Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis. Two Sides of the Locket: Trigger or Cure?. Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026073. https://doi.org/10.4084/mjhid.2026.073

Vancouver

Ceran AA, Yıldız T, Sarı İE, Şeyhanlı A, Yeğin ZA, Özkurt ZN, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis. Two Sides of the Locket: Trigger or Cure?. Mediterranean Journal of Hematology and Infectious Diseases. 2026;18(1):e2026073. doi:10.4084/mjhid.2026.073

BibTeX
@article{Ceran2026,
  author = {Ceran, Ahmet Alparslan and Yıldız, Tuğçe and Sarı, İrem Eser and Şeyhanlı, Ahmet and Yeğin, Zeynep Arzu and Özkurt, Zübeyde Nur and Yağcı, Münci},
  title = {Allogeneic Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis. Two Sides of the Locket: Trigger or Cure?},
  journal = {Mediterranean Journal of Hematology and Infectious Diseases},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {e2026073},
  doi = {10.4084/mjhid.2026.073}
}
Kostenlos starten →